Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people - PubMed (original) (raw)

Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people

Ian P Sinha et al. Trials. 2012.

Abstract

Background: In clinical trials in childhood asthma, outcomes reflecting short-term disease activity are frequently measured, whilst functional status, quality of life (QoL), and long-term treatment effects are rarely assessed. There is also non-uniformity across studies in the selection and measurement of outcomes within these domains. The development of a core outcome set has the potential to reduce heterogeneity between trials, lead to research that is more likely to have measured relevant outcomes, and enhance the value of evidence synthesis by reducing the risk of outcome reporting bias and ensuring that all trials contribute usable information.

Methods: Paediatricians and specialist nurses, identified through the British Paediatric Respiratory Society, completed a two-round Delphi survey. Separate cohorts of parents of children younger than 18 years, recruited in clinics, participated in each round. Young people with asthma, aged at least 13 years, participated in the first round. Outcomes were identified separately for preschool and school-aged children.We identified outcomes considered important in routine clinical assessment by clinicians and parents/young people. In round 1, 46 clinicians suggested outcomes they considered important when deciding whether to adjust a child's asthma therapy regime, and 49 parents/young people were asked, using open questions, how they judged whether their child's (for young people, their own) asthma therapy was appropriate. Two researchers independently classified responses into appropriate, corresponding outcomes.In round 2, 43 clinicians and 50 parents scored, from 0-4, the importance of each outcome suggested by at least 10 % of round 1 responders and selected the three most important.

Results: The most important outcomes, when making shared decisions about regular therapies for school-aged and preschool children with asthma, were daytime and nocturnal symptoms, exacerbations, QoL, and mortality. Results from parents and clinicians were generally concordant, but parents placed more emphasis on long-term treatment effects.

Conclusions: We have developed a methodology to identify outcomes of most relevance to clinicians, parents, and young people when evaluating regularly administered therapies for asthma. Daytime and nocturnal symptoms, exacerbations, QoL, and mortality are particularly important outcomes that should be measured and reported in all clinical trials of regular therapies for children with asthma.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Study flowchart showing participants in each phase of the study.

Similar articles

Cited by

References

    1. Sinha I, Jones L, Smyth RL, Williamson PR. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med. 2008;5(4):e96. doi: 10.1371/journal.pmed.0050096. - DOI - PMC - PubMed
    1. Smith MA, Leeder SR, Jalaludin B, Smith WT. The asthma health outcome indicators study. Aust N Z J Public Health. 1996;20(1):69–75. doi: 10.1111/j.1467-842X.1996.tb01340.x. - DOI - PubMed
    1. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW. et al.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59. doi: 10.1164/rccm.200801-060ST. - DOI - PubMed
    1. Sinha IP, Williamson PR, Smyth RL. Outcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focussed on short term disease activity. PLoS One. 2009;4(7):e6276. doi: 10.1371/journal.pone.0006276. - DOI - PMC - PubMed
    1. Clarke M. Standardising outcomes in paediatric clinical trials. PLoS Med. 2008;5:4. doi: 10.1371/journal.pmed.0050004. - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources